Merger of Pfizer and Wyeth: Distribution of products
This statistic compares the proportion of specialty and primary products before and after the merger of Pfizer with Wyeth. Before the merger, Pfizer's specialty products had a share of 17 percent, while this percentage increased after the merger to some estimated 30 percent as of 2012.